医学
盈利能力指数
食品药品监督管理局
利润(经济学)
制药工业
平衡(能力)
营销
财务
医疗急救
业务
药理学
经济
物理医学与康复
微观经济学
作者
Fred D. Ledley,Sarah Shonka McCoy,Gregory Vaughan,Ekaterina Galkina Cleary
标识
DOI:10.1097/01.ogx.0000695056.94192.53
摘要
(Abstracted from JAMA 2020;323(9):834–843) Virtually all of the US Food and Drug Administration–approved medications in the United States were developed by for-profit companies, thus demonstrating the importance of these corporations in providing medicine to the public. Understanding both drug costs and company profits is vital to creating evidence-based policies that balance the cost of medicine with the industry's ability to innovate.
科研通智能强力驱动
Strongly Powered by AbleSci AI